Article
Version 1
Preserved in Portico This version is not peer-reviewed
Two Things about COVID-19 Might Need Attention
Version 1
: Received: 22 February 2020 / Approved: 23 February 2020 / Online: 23 February 2020 (10:30:06 CET)
How to cite: Jia, X.; Yin, C.; Lu, S.; Chen, Y.; Liu, Q.; Bai, J.; Lu, Y. Two Things about COVID-19 Might Need Attention. Preprints 2020, 2020020315. https://doi.org/10.20944/preprints202002.0315.v1 Jia, X.; Yin, C.; Lu, S.; Chen, Y.; Liu, Q.; Bai, J.; Lu, Y. Two Things about COVID-19 Might Need Attention. Preprints 2020, 2020020315. https://doi.org/10.20944/preprints202002.0315.v1
Abstract
The spread of 2019 novel coronavirus disease (COVID-19) throughout the world has been a severe challenge for public health. The human angiotensin-converting enzyme 2 (ACE2) has a remarkably high affinity binding to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the search for network database and re-analysis of pubic data, we found the level of ACE2 expression in adipose tissue was higher than that in lung tissue, which indicated the adipose tissue might be vulnerable to SARS-CoV-2 as well; the levels of ACE2 expressed by adipocytes and adipose progenitor cells were similar between non-obese individuals and obese individuals, but obese individuals have more adiposes so as to increase the number of ACE2-expressing cells; the expression of ACE2 in tumor tissues posed by five different types of cancers increased significantly compared with that in adjacent tissues. Thus, we suggest that more attentions might be given to obese individuals and the five types of cancer patients during the outbreak of COVID-19.
Keywords
COVID-19; adipose tissue; cancer; ACE2
Subject
Medicine and Pharmacology, Pathology and Pathobiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (3)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
Commenter: Dr. David Johnson
The commenter has declared there is no conflict of interests.
Commenter: Jacquelynn C.
The commenter has declared there is no conflict of interests.
https://pubmed.ncbi.nlm.nih.gov/31484552/
https://diabetes.diabetesjournals.org/content/65/1/19
Commenter:
The commenter has declared there is no conflict of interests.
This is an oversimplification and is against recent data suggesting that ACE2 up-regulation is protective against COVID-19 severity. Females, young people and children have higher ACE2 expression, and at the same time milder disease (https://www.frontiersin.org/articles/10.3389/fped.2020.00206/full).
Studies on SARS-CoV1 showed that after the cells are infected there is an immediate down-regulation (elimination) of ACE2, and this was the reason for the tissue damage (https://www.nature.com/articles/nm1267).
ACE2 is protective, not detrimental. You need to find a different hypothesis to explain the findings that obesity is a risk factor for COVID-19.
Commenter: Nuno Cordeiro
The commenter has declared there is no conflict of interests.